Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[The role of circulating tumor DNA in the diagnosis and prognosis of hepatocellular carcinoma].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology - 20 Dec 2022

Fan Z H, Ren F

Abstract excerpt

Hepatocellular carcinoma (HCC) is one of the common malignant tumors. However, the detection of biomarkers can't meet the clinical needs for the diagnosis and prognosis of HCC now. Circulating tumor DNA (ctDNA) is a highly tumor-specific DNA molecule that exists in the blood circulation. It is part of Circulating cell free DNA (cfDNA) and originates from the primary tumor or metastasis of cancer patients. Now,...

Topics

Join the communities discussing this publication.

Biomarkers, Tumor
Carcinoma, Hepatocellular
Circulating Tumor DNA
DNA
Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 36891725
DOI: 10.3760/cma.j.cn501113-20200419-00197
PMCID: PMC12825095

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[The role of circulating tumor DNA in the diagnosis and prognosis of hepatocellular carcinoma].PMID 36891725Read ↗

Circulating Tumor DNA and Hepatocellular CarcinomaSemantic proximity Read ↗

Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.Semantic proximity Read ↗

Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinomaSemantic proximity Read ↗

Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.Semantic proximity Read ↗

Circulating tumor DNA mutation analysis: advances in its application for early diagnosis of hepatocellular carcinoma and therapeutic efficacy monitoring.Semantic proximity Read ↗

Genetics of Hepatocellular Carcinoma: From Tumor to Circulating DNASemantic proximity Read ↗

Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients’ Management and Therapy OutcomesSemantic proximity Read ↗

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection TechniquesSemantic proximity Read ↗

[Progress of circulating tumor DNA in diagnosis and prognosis of pancreatic cancer].Semantic proximity Read ↗

Circulating Cell-Free DNA in Hepatocellular Carcinoma: Current Insights and OutlookSemantic proximity Read ↗

[Research Progress of Circulating Tumor DNA in Non-small Cell Lung Cancer].Semantic proximity Read ↗

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.